CLINICAL_TRIALS
trial_result
· 2020-06-17
Clinical Trial Update: Saline Versus Albumin Fluid for Extracorporeal Removal With Slow Low Efficiency Dialysis Feasibility Study [Phase 2]
Summary
Phase 2 feasibility study comparing saline vs albumin fluid for extracorporeal removal with slow low efficiency dialysis in acute kidney injury patients.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Ottawa Hospital Research Institute | Conditions: Renal Replacement Therapy, Acute Kidney Injury | Phase 2 | Status: COMPLETED